iguratimod: Clinical Trials

24 trials of iguratimod, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 unknown, 4 completed, 4 recruiting, 3 not yet recruiting. 10 Phase 4, 8 Phase 2, 5 Not applicable, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 410Unknown 4, Completed 3, Recruiting 2, Not yet recruiting 1
Phase 28Unknown 6, Not yet recruiting 1, Recruiting 1
Not applicable5Unknown 3, Not yet recruiting 1, Recruiting 1
Phase 12Recruiting 1, Unknown 1
Phase 31Unknown 1

Follow iguratimod: new trials by email Literature Review of iguratimod trials Research Report on iguratimod

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis
Huoluo Pills, Iguratimod Tablets - Rheumatoid Arthritis
Not applicableNot yet recruitingWangjing Hospital, China Academy of Chinese Medical Sciences2402025-08-112025-08-11
A Study of Iguratimod in Combination With Tofacitinib in RA Patients
Combined therapy of Iguratimod and tofacitinib - Rheumatoid Arthritis (RA
Phase 4Not yet recruitingJie Chang2002025-08-012025-04-25
Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP
Iguratimod, low-dose rituximab - Immune Thrombocytopenia (ITP)
Phase 2Not yet recruitingPeking University People's Hospital1202025-07-012025-07-10
Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
Iguratimod - cGVHD
Phase 1 / Phase 2RecruitingXuzhou Medical University202024-01-102026-09-30
Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement
glucocorticoid plus iguratimod, glucocorticoid plus leflunomide - Autoimmune Diseases
Not applicableRecruitingPeking Union Medical College Hospital602022-07-012026-04-07
Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Iguratimod - Immune Thrombocytopenia
Phase 2UnknownPeking University People's Hospital1002022-03-222022-03-31
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
Iguratimod, placebo - Hand Osteoarthritis, Inflammatory Arthritis
Phase 2 / Phase 3UnknownPeking University People's Hospital1502022-03-012022-02-08
The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets - Primary Sjögren's Syndrome
Phase 4RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine782022-01-142024-10-16
The Clinical Efficacy of Immunomodulators in RA Patients
Iguratimod, Methotrexate, Adalimumab Injection - Arthritis, Rheumatoid
Phase 4RecruitingQilu Hospital of Shandong University4002021-12-222022-11-29
The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Iguratimod, Danazol - ITP, Immune Thrombocytopenia
Phase 2UnknownPeking University People's Hospital1202021-09-012022-05-02
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
Iguratimod - Rheumatoid Arthritis, Therapy
Phase 4UnknownYanfeng Hou1172021-06-012024-03-25
A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
Iguratimod, Placebo - Primary Sjögren Syndrome
Phase 2UnknownJiangsu Simcere Pharmaceutical Co., Ltd.1442021-03-222021-07-19
Iguratimod in Systemic Sclerosis
Iguratimod, Placebo - Systemic Sclerosis, Diffuse
Not applicableUnknownRenJi Hospital202021-01-012020-08-17
The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA
Iguratimod, Tofacitinib, Pred - Arthritis, Rheumatoid
Phase 4CompletedQilu Hospital of Shandong University1002020-03-012023-11-18
The Iguratimod Effect on Lupus Nephritis (IGeLU)
Iguratimod, Cyclophosphamide, Azathioprine - Lupus Nephritis
Phase 2UnknownRenJi Hospital1202017-09-072018-12-19
Iguratimod as Treatment for Refractory Lupus Nephritis
Iguratimod - Lupus Nephritis
Not applicableUnknownRenJi Hospital302017-05-082017-02-27
Study of Iguratimod in Sjögren's Syndrome
Iguratimod - Sjogren's Syndrome
Phase 1 / Phase 2UnknownPeking Union Medical College Hospital302017-02-012017-01-18
Iguratimod in Kidney Transplant Recipients
Iguratimod, Mycophenolate mofetil, Tacrolimus - Kidney Transplantation
Not applicableUnknownThe First Affiliated Hospital with Nanjing Medical University602016-08-012018-08-29
The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment
Iguratimod, MTX, HCQ - Arthritis, Rheumatoid
Phase 4CompletedQilu Hospital of Shandong University4002016-01-012023-11-18
Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis
Iguratimod, Leflunomide, Methotrexate - Rheumatoid Arthritis
Phase 4UnknownJiangsu Simcere Pharmaceutical Co., Ltd.2402013-09-012014-10-27

Showing 20 of 24. Sign in to see all of them.

Conditions studied

Arthritis, Rheumatoid (11)  ·  Purpura, Thrombocytopenic, Idiopathic (3)  ·  Arthritis (2)  ·  Lupus Nephritis (2)  ·  Sjogren's Syndrome (2)  ·  Autoimmune Diseases (1)  ·  Immunoglobulin G4-Related Disease (1)  ·  Nephritis (1)  ·  Recurrence (1)  ·  Scleroderma, Diffuse (1)

Sponsors

Jiangsu Simcere Pharmaceutical Co., Ltd. (5)  ·  Peking University People's Hospital (4)  ·  Qilu Hospital of Shandong University (3)  ·  RenJi Hospital (3)  ·  Peking Union Medical College Hospital (2)  ·  Eisai Co., Ltd. (1)  ·  Jie Chang (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  The First Affiliated Hospital with Nanjing Medical University (1)  ·  Wangjing Hospital, China Academy of Chinese Medical Sciences (1)  ·  Xuzhou Medical University (1)  ·  Yanfeng Hou (1)

Countries

China (20)  ·  Japan (1)

Top investigators

Chunde Bao, MD (2)  ·  Xiao-Hui Zhang, MD (2)  ·  Akiko Yoshimura (1)  ·  Hongzhi Wang (1)  ·  Jieruo Gu, Doctor (1)  ·  Min Gu (1)  ·  Ming Lv, Dr. (1)  ·  Wen Zhang, MD (1)  ·  Xiaohui Zhang (1)  ·  Xiaoyun Yang (1)  ·  Xiaoyun Yang, Dr. (1)  ·  Yan Zhao, Dr. (1)  ·  Yanfeng Hou, Dr. (1)  ·  Ying Guan (1)  ·  Yongmei Han (1)

Results publications

PMID 27919207, PMID 34327344, PMID 34380536, PMID 39056160, PMID 41423293